Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Química Sintética is a prominent Spanish pharmaceutical company dedicated to the development and large-scale manufacturing of Active Pharmaceutical Ingredients (APIs). Established in 1976, the company serves as a core industrial component of the Insud Pharma group, focusing on chemical synthesis and process optimization. Its portfolio includes a diverse range of generic APIs across major therapeutic categories, including cardiovascular, central nervous system, and respiratory health. Química Sintética operates high-capacity manufacturing sites in Spain that adhere to rigorous global quality standards, including US FDA and EU GMP certifications. In addition to its catalog of generic products, the company provides comprehensive CDMO services, supporting partners from initial process development through to commercial production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Química Sintética.